help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morita, Y.
Right arrow Articles by Tilly, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morita, Y.
Right arrow Articles by Tilly, J. L.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ALPHA-AMANITIN
*CYCLOHEXIMIDE
*TRANS-RETINOIC ACID
Endocrinology Vol. 140, No. 6 2696-2703
Copyright © 1999 by The Endocrine Society


ARTICLES

Segregation of Retinoic Acid Effects on Fetal Ovarian Germ Cell Mitosis Versus Apoptosis by Requirement for New Macromolecular Synthesis1

Yutaka Morita2 and Jonathan L. Tilly

Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts 02114

Address all correspondence and requests for reprints to: Jonathan L. Tilly, Ph.D., Massachusetts General Hospital, VBK137E-GYN, 55 Fruit Street, Boston, Massachusetts 02114. E-mail: jtilly{at}partners.org


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Retinoic acid (RA), a naturally occurring metabolite of vitamin A, plays an essential role in regulating cellular growth, differentiation, and death in a variety of tissues, particularly during fetal development. However, essentially nothing is known of the effects of RA on fetal gametogenesis. Using a recently validated system of culturing murine fetal ovaries, herein we sought to characterize the actions of RA on female germ cell proliferation and apoptosis during oogenesis. In the absence of trophic hormone support, approximately 90% of the oogonia and oocytes present in fetal ovaries at the start of culture underwent apoptosis over a 72 h culture period (P < 0.05), whereas provision of 0.01–1 µM RA dose dependently maintained germ cell numbers. In fact, ovaries cultured with 0.1 µM RA for 72 h possessed approximately 30% more oogonia and oocytes as compared with the preculture mean number (P < 0.05). Additional experiments, using in situ DNA 3'-end-labeling and cellular morphology to assess apoptosis coupled with 5-bromo-2'-deoxyuridine incorporation to assess proliferation, revealed that RA acts as both a mitogen and a survival factor for female germ cells. Furthermore, the ability of RA to stimulate germ cell proliferation in cultured fetal ovaries was completely suppressed (P < 0.05) by cotreatment with inhibitors of transcription ({alpha}-amanitin, 0.1 µg/ml) or protein synthesis (cycloheximide, 1.0 µg/ml), whereas RA-mediated suppression of germ cell apoptosis was not affected by cotreatment with either macromolecular synthesis inhibitor (P > 0.05). Moreover, cotreatment of fetal ovaries with 5 µM LY294002, an inhibitor of phosphatidylinositol 3'-kinase, had no effect on RA-promoted germ cell maintenance (P > 0.05). By comparison, the antiapoptotic effects of insulin-like growth factor I on germ cells in cultured fetal ovaries were significantly attenuated by cotreating ovaries with LY294002 (P < 0.05) but not with {alpha}-amanitin or cycloheximide (P > 0.05). Importantly, the effect of RA on the female germ line was also observed in vivo because a single oral administration of 100 mg/kg RA to timed-pregnant female mice resulted in a significantly (P < 0.05) larger endowment of primordial oocytes in female offspring. That these actions were mediated, at least in part, by specific retinoid receptors was demonstrated by the finding of retinoic acid receptor protein in fetal female gonocytes, as assessed by immunohistochemical localization experiments. Collectively, these data indicate that RA can function, in vitro and in vivo, as a potent germ cell survival factor and mitogen during fetal oogenesis in the mouse.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
RETINOIDS, A CLASS of natural and synthetic compounds structurally related to vitamin A, are known to have a profound impact on vertebrate development, cellular differentiation and normal tissue function (1, 2). Retinoic acid (RA) is a physiologic metabolite of vitamin A alcohol (retinol), the latter of which is metabolized in cells via a series of oxidative reactions. In both deficiency and excess, RA is known to cause a diverse spectrum of developmental defects, including craniofacial and limb malformations and abnormalities of the central nervous system (3). Recent studies have shown that RA also modulates apoptosis (2, 4, 5, 6, 7), an important physiological process of cell death involved in tissue development, growth, and homeostasis (8, 9, 10). Interestingly, RA can exert both a positive and negative regulatory effect on the initiation of apoptosis, depending upon the lineage and the differentiation state of the cell exposed to RA (4, 5, 6, 7).

In the context of reproduction, vitamin A deficiency in male rats has been known for many years to cause germ cell degeneration, whereas female rats deprived of vitamin A are unable to reproduce, with pregnancies typically ending in fetal death and resorption (11). More recent work has shown that defective spermatogenesis in vitamin A-starved male rats can be rescued by RA (12), suggesting that RA, and not vitamin A per se, is the critical factor needed for germ cell development. This proposal is supported by the findings of extensive postnatal testicular degeneration in mutant mice lacking expression of functional RA receptor (RAR)-{alpha} (13) or retinoid X receptor (RXR)-ß (14). Unfortunately, neither of these two studies assessed the impact of RAR{alpha} or RXRß mutation on development of the female gonad, and very little else is currently known of RA actions in female germ cells. It has been demonstrated in rats that RA inhibits germinal vesicle breakdown in both denuded and cumulus-enclosed oocytes (15). Moreover, RA has been reported to function as a potent growth activator for murine primordial germ cells (PGC) maintained in vitro without or with feeder cells (16).

To characterize factors involved in regulating female germ cell dynamics during fetal oogenesis, we recently developed an organ culture system for monitoring oogonium and oocyte proliferation and/or apoptosis in mouse fetal ovaries collected on embryonic day 13.5 (17). Using this system, we observed that apoptosis in germ cells caused by trophic hormone deprivation could be effectively suppressed by a combination of stem cell factor and leukemia inhibitory factor or by insulin-like growth factor I (IGF-I) alone (17). Furthermore, activation of the phosphatidylinositol 3'-kinase (PI3K) pathway, independent of p70 S6 kinase, is an essential component of female germ cell survival promoted by either stem cell factor and leukemia inhibitory factor or by IGF-I (17). In the present study, we employed this organ culture system to evaluate the possible role, and mechanisms of action, of RA in modulating fetal ovarian gametogenesis. Additionally, the ability of RA to alter primordial oocyte endowment in neonatal female mice following in utero exposure at embryonic day 13.5 was examined.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Animals
Timed-pregnant female C57Bl/6 mice were obtained from Charles River Laboratories (Wilmington, MA) through the Massachusetts General Hospital Animal Services Facility. Before purchase, females were caged with adult C57Bl/6 males overnight, and insemination was verified the following morning by the presence of a copulation plug in the vagina. The day of observation of a plug was considered embryonic day 0.5 (e0.5). Timed-pregnant mice were received from the supplier on the day corresponding to e12 for overnight acclimation before the experiments. All experimental protocols with mice used in this study were reviewed and approved by the Massachusetts General Hospital Institutional Animal Care and Use Committee and were performed in strict accordance with the NIH Guidelines for the Care and Use of Laboratory Animals.

Microsurgical isolation of genital ridges and organ cultures
Dissection of genital ridges was performed under sterile conditions on e13.5, as originally described for studies of rodent Müllerian duct regression (18) and as more recently detailed by our laboratory (17). Once all cultures were prepared, two to three genital ridges were immediately fixed as "Time 0" data points (see below), and the remaining genital ridges were cultured for in a humidified chamber gassed with 5% CO2–95% air in the absence or presence of experimental treatments. In the first set of experiments, cultures were carried out by treating ovaries for 72 h without or with 0.01–1.0 µM all-trans-RA (Sigma Chemical Co., St. Louis, MO). To investigate the mechanisms of action of RA in this model system, a second set of experiments was performed by treating ovaries for 72 h without or with 0.1 µM all-trans-RA in the absence or presence of 0.1 µg/ml of the RNA polymerase II inhibitor, {alpha}-amanitin (Sigma Chemical Co.), 1.0 µg/ml of the protein synthesis inhibitor, cycloheximide (Sigma Chemical Co.), or 5 µM of the PI3K inhibitor, LY294002 (Sigma Chemical Co.). The latter set of experiments with LY294402 were included to determine if the seemingly broad requirement for PI3K in female gonocyte survival mediated by other external stimuli (i.e.. cytokines and growth factors; 17) is applicable to RA as well. Selection of the final doses of inhibitors used was based on previous studies (17, 19, 20), as well as on empirical dose-response studies in our laboratory with fetal mouse ovaries in organ culture (data not shown). As a control for potential macromolecular synthesis inhibitor toxicity, fetal ovaries were also cultured without and with 50 ng/ml of human recombinant IGF-I (Promega Corp., Madison, WI) in the absence or presence of 0.1 µg/ml {alpha}-amanitin or 1.0 µg/ml cycloheximide. This growth factor was selected based on our recent observations that IGF-I, acting via PI3K, is a potent survival factor for female gonocytes in cultured fetal ovaries (17).

Histology
Freshly isolated (Time 0, no culture) genital ridges or cultured genital ridges at the conclusion of the experimental manipulation were covered with 2% low-melting temperature agarose maintained at 44 C, and the agarose was allowed to harden. The agarose-coated tissue was then fixed in neutral-buffered 4% formaldehyde with 5% Bouin’s fluid, dehydrated in ethanol, cleared in xylenes, embedded in paraffin, and serially sectioned at 6 µm thickness. In some cases, every serial section of the ovary was aligned in order on glass microscope slides for hematoxylin and eosin (H/E) staining. These sections were used for general histologic analysis of cellular morphology, as well as for determination of germ cell counts (see below). In H/E-stained sections, cells possessing lightly stained round nuclei along with a maintenance of cytoplasmic volume and easily discernible spherical plasma membranes were considered nonapoptotic, whereas cells showing nuclear condensation (basophilia), cytoplasmic shrinkage, and convoluted plasma membranes were considered apoptotic (21). As previously established for studies of the fetal ovary (22, 23, 24), germ cells were distinguished from somatic cells based on differences in cellular size (germ cells being much larger than somatic cells) and morphology (germ cells and their nuclei being spherical as opposed to somatic cells being squamous with flattened nuclei). Furthermore, morphological identification of germ cells was confirmed by alkaline phosphatase staining in preliminary unpublished studies conducted during the validation of this culture model (17).

Germ cell counts
Following histologic preparation and H/E-staining (see Histology section), the total number of nonapoptotic germ cells in sections taken at sites approximately one-third, one-half, and two-thirds through the fetal ovary, along the long axis, were counted. Each ovary was given a numerical code so that all germ cell counts were conducted without knowledge of treatment group. After all counts were completed, the mean number of germ cells per section was determined for each ovary by taking the mean of the values from the three sections, each ovary was decoded, and the values were then assigned to the corresponding treatment group for analysis (17).

In situ DNA 3'-end labeling (ISEL)
The occurrence of apoptosis in germ cells was also assessed by monitoring the presence of DNA fragmentation in situ, as described previously (17, 25). Slides were analyzed by conventional light microscopy after light counterstaining with hematoxylin, and those cells exhibiting brown staining from the colorimetric reaction were considered positive for DNA fragmentation (17, 25). Negative controls, conducted by omitting the terminal deoxynucleotidyl transferase enzyme, yielded no reaction product (data not shown).

Analysis of germ cell proliferation
To investigate further the effects of RA on mitosis, fetal ovaries were cultured in the absence or presence of 0.1 µM RA, without or with 0.1 µg/ml {alpha}-amanitin or 1.0 µg/ml cycloheximide, for 24 h, after which 5-bromo-2'-deoxyuridine (BrdU; Sigma Chemical Co.) was added to each well at a final concentration of 30 µM. All cultures were continued for an additional 2 h at 37 C (pulse-labeling), after which tissues were fixed, embedded in paraffin, section and analyzed by immunohistochemistry for sites of BrdU incorporation as a marker of new DNA synthesis (26) under conditions detailed previously (17, 27, 28, 29). Negative controls, conducted by omitting the primary antibody, yielded no reaction product (data not shown). Slides were analyzed by conventional light microscopy after light counterstaining with hematoxylin, and those cells exhibiting brown staining were considered positive for BrdU incorporation.

In vivo effects of RA on germ cell endowment
Single doses of vehicle (dimethylsulfoxide:corn oil, 1:4, vol:vol) or 100 mg/kg RA were administrated to timed-pregnant female mice on e13.5 by oral gavage (total volume of 0.4 ml/mouse), and the mice were allowed to complete gestation and parturition. The dose of RA used was based on previous studies of RA treatment in vivo and was selected as one that does not cause caudal regression syndrome (30). On the day of birth, neonatal ovaries were collected from female offspring and fixed (0.34 N glacial acetic acid, 10% formalin, 28% ethanol). Ovaries were then dehydrated, cleared in xylenes, embedded in paraffin, and serially sectioned at 8 µm thickness. Every serial section of the ovary was aligned in order on glass microscope slides, stained and analyzed for the number of primordial oocytes per section in every fifth section through the entire ovary. Each ovary was given a numerical code so that all primordial oocyte counts were conducted without knowledge of treatment group. After all counts were completed, the total number of primordial oocytes per ovary was calculated and used as a measure of germ cell endowment (31, 32, 33).

Analysis of RAR and RXR expression
Fetal ovaries (or adult mouse uterus as a positive control; 34) were processed for immunohistochemical localization of RAR and RXR proteins using high-temperature antigen unmasking procedures detailed previously (17, 27, 28, 29). For these experiments, a 1:50 dilution of a rabbit polyclonal antiserum against the full-length human RAR{gamma} isoform, which detects all three isoforms of RAR ({alpha}, ß, and {gamma}) of human, mouse and rat origin (clone M-454; Santa Cruz Biotechnology, Inc., Santa Cruz, CA) and a rabbit polyclonal antiserum raised against the ligand binding domain of human RXR{alpha}, which detects all three isoforms of RXR ({alpha}, ß and {gamma}) of human, mouse and rat origin (clone {Delta}N 197; Santa Cruz Biotechnology, Inc.) were used. Chromogenic detection of the sites of antigen-primary antibody complexes was performed by incubating sections for 1 h with a 1:200 dilution of a biotinylated goat antirabbit IgG antibody (Vector Laboratories, Inc.), followed by addition of avidin-biotin horseradish peroxidase complex components (ABC kit; Vector Laboratories, Inc.) at 20 C for 45 min. Sections were then washed and incubated with 0.5 mg/ml 3,3'-diaminobenzidine and 0.03% hydrogen peroxide for 1 min at 20 C, and colorimetric reactions (generation of a brown reaction product) were terminated by placing the slides in a buffer consisting of 10 mM Tris-HCl and 1 mM EDTA (pH 8.0). Negative controls, conducted by omitting the primary antibody, yielded no reaction product (data not shown). Slides were analyzed by conventional light microscopy after light counterstaining with hematoxylin.

Data presentation and statistical analysis
In each experiment for the in vitro studies, two to three genital ridges were used for each treatment group, and all experiments were independently replicated at least three times. To assess the in vivo effects of RA on primordial oocyte endowment, four timed-pregnant female mice were used for each treatment group, and one randomly selected ovary of the pair from one female neonate in each litter was used to assess oocyte number. Therefore, the quantitative data of germ cell numbers represent the mean ± SEM of combined results obtained from analysis of a minimum of six fetal ovaries or four neonatal ovaries in each treatment group. One-way ANOVA was used to compare mean values of the various treatment groups, followed by Scheffé’s F test to determine significant differences at P < 0.05. Photomicrographs of tissue histology (H/E-staining) or histochemistry (ISEL of DNA integrity, immunohistochemical analysis of BrdU incorporation, immunohistochemical analysis of retinoic acid receptors), representative of results obtained in the replicate experiments, are presented for qualitative analysis.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Occurrence of germ cell apoptosis in cultured fetal ovaries
Consistent with our recent findings (17), freshly isolated e13.5 ovaries contained only healthy (nonapoptotic) germ cells (Fig. 1Go, A and D). In vitro culture of ovaries without trophic hormone support resulted in a time-dependent increase in the number of germ cells displaying chromatin condensation, cytoplasmic shrinkage, and DNA fragmentation such that most germ cells remaining at 72 h were apoptotic (Fig. 1Go, B and E). Morphometric analysis (germ cell counts) revealed that the number of healthy oogonia and oocytes present in fetal ovaries after 72 h of culture was significantly decreased to approximately 10% of the preculture (Time 0) mean number (Fig. 2Go).



View larger version (132K):
[in this window]
[in a new window]
 
Figure 1. Histochemical analyses of mouse fetal ovaries before and after in vitro culture in the absence or presence of RA. A–C, Representative germ cell morphology, as assessed by hematoxylin and eosin staining, in ovaries before culture (A) or following a 72-h culture without (B; arrows demarcate typical apoptotic gonocytes) or with 0.1 µM RA (C). D–F, The absence or presence of apoptosis was further confirmed by ISEL analysis of DNA cleavage (panels D, E, and F, corresponding to freshly isolated ovaries, ovaries cultured for 72 h without hormone and ovaries cultured for 72 h with 0.1 µM RA, respectively), with brown staining indicative of nuclei labeled positive for DNA fragmentation. G and H, Representative results from analysis of germ cell proliferation in cultured fetal mouse ovaries. Fetal ovaries were cultured without (G) or with 0.1 µM RA (H) for 24 h, after which BrdU was added to each well at a final concentration of 30 µM. All cultures were continued for an additional 2 h at 37 C, after which the tissues were fixed, embedded in paraffin, sectioned from the center of the ovary (long axis), and analyzed by immunohistochemistry for the occurrence of BrdU incorporation (brown staining) as a marker of new DNA synthesis associated with cellular proliferation. These data are representative of results obtained in at least three separate experiments containing two to three ovaries per treatment group in each experiment. Original magnifications: A–C, x400; D–H, x600.

 


View larger version (75K):
[in this window]
[in a new window]
 
Figure 2. Antiapoptotic and proliferative actions of RA in cultured fetal mouse ovaries. Ovaries with attached genital ridges were fixed immediately (Time 0), or were cultured for 72 h in the absence (controls, CON) or presence of 0.01–1.0 µM RA. Tissues were then fixed, sectioned, stained, and analyzed for the numbers of nonapoptotic germ cells present per section (see Materials and Methods for details). Values are the mean ± SEM of combined data from at least three independent experiments with two to three ovaries used per treatment group in each experiment. Different superscript lettersindicate significant differences (P < 0.05).

 
Suppression of germ cell apoptosis by RA
Inclusion of RA in the culture medium significantly attenuated germ cell apoptosis over the 72-h culture period (Fig. 1Go, C and F). Furthermore, morphometric analysis indicated that the number of healthy oogonia and oocytes remaining in ovaries after 72 h of culture with 0.1 µM RA was 12.2 ± 1.0-fold greater than that in untreated control ovaries cultured in parallel (Fig. 2Go). Furthermore, the number of oogonia and oocytes in ovaries cultured for 72 h in the presence of higher doses of RA (0.1 and 1.0 µM) was significantly greater than preculture mean number (P < 0.05) (Fig. 2Go), suggesting that RA not only prevents apoptosis but also promotes mitosis in developing female germ cells.

Stimulation of germ cell proliferation by RA
In fetal ovaries cultured for 24 h without RA, we could not detect evidence of BrdU incorporation in cells of any section analyzed (Fig. 1GGo). However, ovaries cultured in the presence of 0.1 µM RA possessed many BrdU-positive germ cells (Fig. 1HGo), confirming that RA is a potent stimulator of germ cell proliferation in cultured fetal ovaries.

Mechanisms of action RA in germ cells: mitosis vs. apoptosis
The ability of RA to induce germ cell mitosis in cultured fetal ovaries (Fig. 1HGo and Table 1Go) was completely suppressed by cotreatment with 0.1 µg/ml {alpha}-amanitin or 1.0 µg/ml cycloheximide (Table 1Go). However, the ability of RA to prevent germ cell apoptosis was not affected by cotreatment with either of these two macromolecular synthesis inhibitors (Table 1Go). Morphometric analysis revealed that germ cell counts in fetal ovaries cocultured for 72 h with RA and {alpha}-amanitin or cycloheximide were reduced to approximately 30% of those in fetal ovaries cultured for 72 h with RA alone (Fig. 3Go). In contrast, LY294002 cotreatment did not alter the germ cell response to RA following a 72-h culture (Fig. 3Go). As a control to test for nonspecific toxicity associated with the macromolecular synthesis inhibitors, we observed that IGF-I-promoted germ cell survival was not altered by {alpha}-amanitin or cycloheximide cotreatment (Fig. 3Go). Furthermore, germ cell counts in ovaries treated with {alpha}-amanitin or cycloheximide were comparable to those obtained in control cultures without inhibitor (P > 0.05) (Fig. 3Go).


View this table:
[in this window]
[in a new window]
 
Table 1. Antagonism of RA-promoted germ cell proliferation, but not RA-mediated germ cell survival, by inhibition of new macromolecular synthesis

 


View larger version (42K):
[in this window]
[in a new window]
 
Figure 3. Cotreatment with {alpha}-amanitin or cycloheximide, but not LY294002, attenuates RA-promoted gonocyte survival and proliferation in cultured fetal mouse ovaries. Ovaries with attached genital ridges were fixed immediately (Time 0) or were cultured for 72 h in the absence (controls, CON) or presence of 0.1 µg/ml {alpha}-amanitin ({alpha}-AM), 1 µg/ml cycloheximide (CHX), 0.1 µM RA, RA plus 0.1 µg/ml {alpha}-amanitin, RA plus 1 µg/ml cycloheximide, or RA plus 5 µM LY294002 (LY). Ovaries were also cultured for 72 h in the presence of 50 ng/ml IGF-I, IGF-I plus 0.1 µg/ml {alpha}-amanitin, or IGF-I plus 1 µg/ml cycloheximide. Tissues were fixed, sectioned, stained, and assessed for total numbers of nonapoptotic germ cells present per section. The data represent the mean ± SEM of combined results from at least three independent experiments with two to three ovaries used per treatment group in each experiment. Different superscript letters indicate significant differences (P < 0.05).

 
In vivo effects of RA on primordial oocyte endowment
The number of primordial oocytes present in ovaries of neonatal female mice following in utero exposure to RA was significantly higher than that of control group (Fig. 4AGo). Furthermore, gross histologic analysis revealed no abnormalities in ovaries of neonates exposed to RA during fetal gestation (Fig. 4CGo) as compared with vehicle controls (Fig. 4B).



View larger version (65K):
[in this window]
[in a new window]
 
Figure 4. Effects of RA on fetal ovarian gametogenesis in vivo. Single oral doses of 100 mg/kg RA were administered to timed-pregnant female mice on e13.5. The animals were allowed to complete gestation together with vehicle-treated animals (CON, controls), and neonatal ovaries were collected, fixed, sectioned and stained. Panel A shows the numbers of primordial oocytes endowed per ovary, whereas Panels B and C represent the gross histologic appearance of ovaries of neonatal female mice exposed in utero to vehicle (CON) or RA, respectively. Values in panel A are the mean ± SEM of combined data from four independent experiments, and different superscript letters indicate significant differences (P < 0.05). Original magnifications: B, C, x400.

 
Expression of RAR and RXR in fetal ovaries
As a final series of studies to confirm expression of RA receptors in female germ cells of the developing fetal ovary, immunohistochemical analyses of e13.5 ovarian sections indicated that RAR (Fig. 5Go, A and B), but not RXR (Fig. 5CGo), was expressed in gonocytes at this stage of fetal development. In freshly isolated ovaries, the majority of RAR was found in the cytoplasm of germ cells (Fig. 5AGo), whereas a 24-h culture with 0.1 µM RA caused a redistribution of RAR to the nucleus (Fig. 5BGo). In all cases, low or no expression of RAR or RXR was observed in the surrounding somatic cells (Fig. 5Go, A–C). To confirm that the RXR immunostaining conditions were appropriate for detection of the protein, RXR-positive stromal cells were easily detected in adult mouse uterine tissue (Fig. 5D).



View larger version (189K):
[in this window]
[in a new window]
 
Figure 5. Immunohistochemical localization of RAR and RXR. A and B, RAR immunostaining in fetal mouse ovaries before (A) and after (B) a 24 h culture with 0.1 µM RA. Note the cytosolic to nuclear redistribution of RAR upon retinoid treatment (indicated by arrows). C and D, RXR immunostaining in fetal ovaries (C) or adult mouse uterus (D, positive control). Note that RXR is absent in fetal ovaries but easily detected in uterine stromal cells (indicated by arrows). These data are representative of results obtained in three independent experiments. Original magnifications: A–C, x600; D, x400.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
In this report, we identified RA as a potent survival factor and mitogen for female germ cells in fetal mouse ovaries cultured in vitro. The ability of RA to stimulate proliferation of oogonia in the fetal ovary is consistent with its reported actions as a primordial germ cell mitogen (16), although its dual function as an antiapoptotic factor in female germ cells is a novel observation. Moreover, these data are the first to show that the RNA polymerase II inhibitor, {alpha}-amanitin, and the protein synthesis inhibitor, cycloheximide, abolish the effects on RA on oogonium proliferation but are without effect on RA-mediated germ cell survival. Consequently, we can deduce that out of the total number of germ cells present in fetal ovaries cultured for 72 h with 0.1 µM RA, approximately two-thirds of these are derived from mitogenesis (this is the proportion of germ cells lost by cotreatment with macromolecular synthesis inhibitors), whereas the remaining one-third are preserved as a result of apoptosis inhibition.

The classic intracellular pathway of RA action involves receptors for RA that mediate nuclear genomic responses. These receptors can be classified into two major groups: RAR {alpha}, ß, and {gamma}; and RXR {alpha}, ß, and {gamma} (35, 36, 37). Both RAR and RXR are ligand-dependent transcriptional factors that homo- and heterodimerize to modulate expression of target genes by binding with specific retinoic acid response elements contained in the regulatory regions of these genes. In addition to the receptors, however, there are two low molecular mass cytoplasmic proteins involved in RA signal transduction that are referred to as cellular RA-binding protein (CRABP) type I and CRABP type II (38). The currently proposed functions of CRABPs include "solubilization" of their hydrophobic ligand and, in some cases, regulation of RA metabolism by restricting access of the vitamin A metabolite to certain catabolic enzymes. One as yet unexplored possible function for CRABPs may be comparable to that described for other cytoplasmic steroid hormone receptors that transduce signals via a variety of nongenomic actions including alterations in calcium flux and cGMP accumulation (39, 40, 41, 42).

Many of the RAR and RXR isoforms, as well as CRABPs, are known to be expressed in the postnatal gonads and, in particular germ cells, of diverse species (for examples, see Refs. 43, 44, 45, 46). However, it remains to be determined if the reproductive defects observed in RAR and RXR mutant mice (13, 14) arise from a germ cell autonomous nature or indirectly via defective function the surrounding somatic cell lineages. Because germ cells express RARs, RXRs, and CRABPs, it may be that the genomic actions of RA observed herein (i.e. oogonium mitosis) are mediated via the classic nuclear RA receptors, whereas the antiapoptotic effects of RA are transduced via the cytosolic binding proteins that work independently of new gene expression. In support of the first stipulation of this hypothesis, we observed by immunohistochemical analyses that RAR, but not RXR, proteins were expressed in germ cells of fetal ovaries at e13.5. Interestingly, in freshly isolated gonads RAR immunoreactivity was essentially restricted to the cytosolic compartment of the gonocytes. Based on previous observations that unbound or free RAR exists in the cytoplasm (35, 47), these findings suggest that endogenous RA is low or absent at this time in fetal ovarian development. However, in vitro culture of fetal ovaries with RA resulted in nuclear translocation of RAR in gonocytes, consistent with the notion of receptor activation leading to new gene expression (35). Unfortunately, we were unable to obtain antibodies for CRABPI or -II to perform parallel investigations of fetal ovarian germ cell expression of these proteins. Moreover, because there are no reported CRABP-specific inhibitors or activators, generation of CRABP mutant mouse lines will be needed to provide the necessary tools to directly test the requirement for CRABPs as mediators of RA effects on female germ cell survival.

Of further interest, the antiapoptotic actions of IGF-I in female germ cells were not abrogated by inhibitors of new messenger RNA and protein synthesis, suggesting that the acute regulation of apoptosis in this model by diverse extracellular factors is executed via proteins and other factors preexistent in the developing oogonia and oocytes. Moreover, inhibition of PI3K with LY294002 (or wortmannin; data not shown) did not alter the mitogenic or survival response of germ cells to RA in cultured fetal ovaries, despite the fact that these inhibitors are known to be potent antagonists to fetal ovarian germ cell survival promoted by cytokines and IGF-I (17). Consequently, there must exist multiple signaling pathways, some requiring PI3K and others not, in developing female germ cells that are initially used as a response to external survival factors. However, based on our recent observations of a greater primordial follicle endowment in ovaries of neonatal female mice harboring a targeted disruption of a downstream death effector gene (i.e. Casp2; 29), it is likely that these early signaling pathways converge upon a final common pathway of apoptosis regulators in germ cells that either carry out or repress cell death execution (48, 49).

Lastly, it is important to note that the ability of RA to increase germ cell numbers in cultured fetal ovaries was replicated using an in vivo approach of RA exposure during fetal gestation. Aside from our recent observations with caspase-2 deficient mice (32), to our knowledge this is the only other report of an experimental manipulation that produces a surfeit of primordial oocytes in ovaries of neonatal mice. Furthermore, we observed no gross histopathologic alterations in ovaries of mice exposed to RA in utero, although it remains to be established if this increased primordial oocyte reserve will alter normal reproductive development and function, such as time to puberty and time to reproductive senescence. Based on our recent observations that the surplus of primordial follicles in young adult female mice produced as a result of Bax-deficiency does in fact lead to a dramatic extension of ovarian lifespan (33), these experiments will be important follow-up studies to support and extend the observations reported herein.

From these data, we conclude that RA can function as a potent survival factor and activator of germ cell proliferation in the developing fetal mouse ovary. Furthermore, the ability of in utero RA exposure to produce an overendowment of primordial oocytes in neonatal female mice supports the usefulness of the in vitro culture system and, more importantly, provides a unique model to explore the impact of excess follicle numbers at birth on functional lifespan of the female gonad. Specific modulation of new gene expression and protein synthesis by RA appears to play a crucial role in its actions as a mitogen for oogonia. However, the identity of the nongenomic intracellular pathways and mechanisms used by RA to prevent germ cell death during female gametogenesis remain to be elucidated.


    Acknowledgments
 
We would like to thank Dr. Zahra Zakeri (Queens College, Flushing, NY) for insightful early discussions on retinoids and developmental apoptosis, and Dr. Gloria I. Perez and Mr. Sam Riley for technical assistance with the photomicroscopy and figure preparation.


    Footnotes
 
1 This study was supported by NIH Grants R01-ES-08430, R01-AG-12279 and R01-HD-34226, and by Vincent Memorial Research Funds. Back

2 On leave from the Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, Tokyo 113, Japan, and supported by the Japanese Society for the Promotion of Science. Back

Received September 29, 1998.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Brockes JP 1989 Retinoids, homeobox genes, and limb morphogenesis. Neuroendocrinology 2:1285–1294
  2. Tabin CJ 1991 Retinoids, homeoboxes, and growth factors: toward molecular models for limb development. Cell 66:199–217[CrossRef][Medline]
  3. Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, Braun JT, Curry CJ, Fernhoff PM, Grix AW, Lott IT 1985 Retinoic acid embryopathy. N Engl J Med 313:837–841[Abstract]
  4. Nagy L, Thomazy VA, Shipley GL, Fesus L, Lamp W, Heyman RA, Chandraratna RAS, Davies PJA 1995 Activation of retinoid X receptors induces apoptosis in HL-60 cell lines. Mol Cell Biol 15:3540–3551[Abstract]
  5. Ponzoni M, Bocca P, Chiesa V, Decensi A, Pistoia V, Roffaghello L, Rozzo C, Montaldo PG 1995 Differential effects of N-(4-hydroxyphenyl) retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation. Cancer Res 55:853–861[Abstract/Free Full Text]
  6. Toma S, Isnardi L, Raffo P, Dastoli G, DeFrancisci E, Riccardi L, Palumbo R, Bollag W 1997 Effects of all-trans retinoic acid and 13-cis retinoic acid on breast cancer cell lines: growth inhibition and apoptosis induction. Int J Cancer 70:619–627[CrossRef][Medline]
  7. Bissonnette RP, Brunner T, Lazarchik SB, Yoo NJ, Boehm MF, Green DR, Heyman RA 1995 9-cis retinoic acid inhibition of activation-induced apoptosis is mediated via regulation of Fas ligand and requires retinoic acid receptor and retinoid X receptor activation. Mol Cell Biol 15:5576–5585[Abstract]
  8. Kerr JFR, Wyllie AH, Currie AR 1972 Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239–257[Medline]
  9. Thompson CB 1995 Apoptosis in the pathogenesis and treatment of disease. Science 267:1456–1462[Abstract/Free Full Text]
  10. Yang E, Korsmeyer SJ 1996 Molecular thanatopsis: a discourse on the BCL-2 family and cell death. Blood 88:386–401[Free Full Text]
  11. Thompson JN, Howell JM, Pitt GAJ 1964 Vitamin A and reproduction in rats. Proc Royal Soc Lond (B) 159:510–535
  12. van Pelt AM, de Rooij DG 1991 Retinoic acid is able to reinitiate spermatogenesis in vitamin A-deficient rats and high replicate doses support the full development of spermatogenic cells. Endocrinology 128:697–704[Abstract]
  13. Lufkin T, Lohnes D, Mark M, Dierich A, Gorry P, Gaub MP, LeMeur M, Chambon P 1993 High postnatal lethality and testis degeneration in retinoic acid receptor {alpha} mutant mice. Proc Natl Acad Sci USA 90:7225–7229[Abstract/Free Full Text]
  14. Kastner P, Mark M, Leid M, Gransmuller A, Chin W, Grondona JM, Décimo D, Krezel W, Dierich A, Chambon P 1996 Abnormal spermatogenesis in RXRß mutant mice. Genes Dev 10:80–92[Abstract/Free Full Text]
  15. Pellicer A, Parmer TG, Stoane JM, Behrman HR 1989 Desensitization to follicle-stimulating hormone in cumulus cells is coincident with hormone induction of oocyte maturation in the rat follicle. Mol Cell Endocrinol 64:179–188[CrossRef][Medline]
  16. Koshimizu U, Watanabe M, Nakatsuji N 1995 Retinoic acid is a potent growth activator of mouse primordial germ cells in vitro. Dev Biol 168:683–685[CrossRef][Medline]
  17. Morita, Y, Manganaro TM, Tao X-J, Martimbeau S, Donahoe PK, Tilly JL 1999 Requirement for phosphatidylinositol-3'-kinase in cytokine-promoted germ cell survival during fetal oogenesis in the mouse. Endocrinology 140:941–949[Abstract/Free Full Text]
  18. Donahoe PK, Ito Y, Hendren III WH 1977 A graded organ culture assay for the detection of Müllerian inhibiting substance. J Surg Res 23:141–148[CrossRef][Medline]
  19. Koumenis C, Giaccia A 1997 Transformed cells require continuous activity of RNA polymerase II to resist oncogene-induced apoptosis. Mol Cell Biol 17:7306–7316[Abstract]
  20. Koh J, Wie MB, Gwag BJ, Sensi SL, Canzoniero LMT, Demaro J, Csernansky C, Choi DW 1995 Staurosporine-induced neuronal apoptosis. Exp Neurol 135:153–159[CrossRef][Medline]
  21. Kerr JFR, Winterford CM, Harmon BV 1994 Morphological criteria for identifying apoptosis. In: Celis JE (ed) Cell Biology: A Laboratory Handbook. Academic Press, San Diego, vol 1, pp 319–329
  22. Byskov AG 1986 Differentiation of the mammalian embryonic gonad. Physiol Rev 66:71–117[Abstract/Free Full Text]
  23. Lavoir MC, Basrur PK, Betteridge KJ 1994 Isolation and identification of germ cells from fetal bovine ovaries. Mol Reprod Dev 37:413–424[CrossRef][Medline]
  24. Motta PM, Makabe S, Naguro T, Correr S 1994 Oocyte follicle cells association during development of human ovarian follicle. A study by high resolution scanning and transmission electron microscopy. Arch Histol Cytol 57:369–394[Medline]
  25. Tilly JL 1994 Use of the terminal transferase DNA labeling reaction for the biochemical and in situ analysis of apoptosis. In: Celis JE (ed) Cell Biology: A Laboratory Handbook. Academic Press, San Diego, vol 1, pp 330–337
  26. Gratzner HG 1992 Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: a new reagent for detection of DNA replication. Science 218:474–475
  27. Shi SR, Key ME, Kalra KL 1991 Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39:741–748[Abstract]
  28. Tao X-J, Tilly KI, Maravei DV, Shifren JL, Krajewski S, Reed JC, Tilly JL, Isaacson KB 1997 Differential expression of members of the bcl-2 gene family in proliferative and secretory human endometrium: glandular epithelial cell apoptosis is associated with increased expression of bax. J Clin Endocrinol Metab 82:2738–2746[Abstract/Free Full Text]
  29. Kugu K, Ratts VS, Piquette GN, Tilly KI, Tao X-J, Martimbeau S, Aberdeen GW, Krajewski S, Reed JC, Pepe GJ, Albrecht ED, Tilly JL 1998 Analysis of apoptosis and expression of bcl-2 gene family members in the human and baboon ovary. Cell Death Differ 5:67–76[CrossRef][Medline]
  30. Padmanabhan R 1998 Retinoic acid-induced caudal regression syndrome in the mouse fetus. Reprod Toxicol 12:139–151[CrossRef][Medline]
  31. Ratts VS, Flaws JA, Kolp R, Sorenson CM, Tilly JL 1995 Ablation of bcl-2 gene expression decreases the number of oocytes and primordial follicles established in the post-natal female mouse gonad. Endocrinology 136:3665–3668[Abstract]
  32. Bergeron L, Perez GI, Macdonald G, Shi L, Sun Y, Jurisicova A, Varmuza S, Latham KE, Flaws JA, Salter JCM, Hara H, Moskowitz MA, Li E, Greenberg A, Tilly JL, Yuan J 1998 Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev 12:1304–1314[Abstract/Free Full Text]
  33. Perez GI, Robles R, Knudson CM, Flaws JA, Korsmeyer SJ, Tilly JL 1999 Prolongation of ovarian lifespan into advanced chronological age by Bax-deficiency. Nat Genet 21:200–203[CrossRef][Medline]
  34. Kumarendran MK, Mattews CJ, Levasseur MD, Prentice A, Thomas EJ, Redfern CP 1994 Oestrogen and progesterone do not regulate the expression of retinoic acid receptors and retinoid X receptors in human endometrial stromal cells in vitro. Hum Reprod 9:229–234[Abstract/Free Full Text]
  35. Giguére V 1994 Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling. Endocr Rev 15:61–79[CrossRef][Medline]
  36. Chambon P 1994 The retinoid signaling pathway: molecular and genetic analyses. Semin Cell Biol 5:115–125[CrossRef][Medline]
  37. Manglesdorf DJ, Umesono K, Evans RM 1994 Retinoid acid receptors. In: Sporn MB, Roberts AB, Goodman DS (eds) The Retinoids. Raven Press, New York, pp 319–349
  38. Ong DE, Newcomer ME, Chytil F 1994 Cellular retinoid binding proteins. In: Sporn MB, Roberts AB, Goodman DS (eds) The Retinoids. Raven Press, New York, pp 283–317
  39. Barsony J, Marx SJ 1991 Rapid accumulation of cyclic GMP near vitamin D receptors. Proc Natl Acad Sci USA 88:1436–1440[Abstract/Free Full Text]
  40. Christ M, Sippel K, Eisen C, Wehling M 1994 Non-classical receptors for aldosterone in plasma membranes from pig kidneys. Mol Cell Endocrinol 99:R31–R34
  41. Machelon V, Nome F, Tesarik J 1998 Nongenomic effects of androstenedione on human granulosa luteinizing cells. J Clin Endocrinol Metab 83:263–269[Abstract/Free Full Text]
  42. Farach-Carson MC, Ridall AL 1998 Dual 1,25-dihydroxyvitamin D3 signal response pathways in osteoblasts: cross-talk between genomic and membrane-initiated pathways. Am J Kidney Dis 31:729–742[Medline]
  43. Eskild W, Ree AH, Levy FO, Jahnsen T, Hansson V 1991 Cellular localization of mRNAs for retinoic acid receptor-{alpha}, cellular retinol binding protein, and cellular retinoic acid-binding protein in rat testis: evidence for germ cell-specific mRNAs. Biol Reprod 44:53–61[Abstract]
  44. Huang HF, Li MT, Pogach LM, Qian L 1994 Messenger ribonucleic acid of rat testicular retinoic acid receptors: developmental pattern, cellular distribution, and testosterone effects. Biol Reprod 51:541–550[Abstract]
  45. Zhuang YH, Ylikomi T, Lindfors M, Piippo S, Tuohimaa P 1994 Immunolocalization of retinoic acid receptors in rat, mouse and human ovary and uterus. J Steroid Biochem Mol Biol 48:61–68[CrossRef][Medline]
  46. Gaemers IC, van Pelt AM, van der Saag PT, Hoogerbrugge JW, Themmen AP, de Rooij DG 1998 Differential expression pattern of retinoid X receptors in adult murine testicular cells implies varying roles for these receptors in spermatogenesis. Biol Reprod 58:1351–1356[Abstract/Free Full Text]
  47. Akmal KM, Dufour JM, Vo M, Higginson S, Kim KH 1998 Ligand-dependent regulation of retinoic acid receptor {alpha} in rat testis: in vivo response to depletion and repletion of vitamin A. Endocrinology 139:1239–1248[Abstract/Free Full Text]
  48. Tilly JL, Tilly KI, Perez GI 1997 The genes of cell death and cellular susceptibility to apoptosis in the ovary: a hypothesis. Cell Death Differ 4:180–187[CrossRef][Medline]
  49. Tilly JL, Robles R 1999 Apoptosis and its impact in clinical reproductive medicine. In: Fauser BCJM, Rutherford AJ, Strauss III JF, Van Steirteghem A (eds) Molecular biology in reproductive medicine. Parthenon Publishing, New York, pp 79–101



This article has been cited by other articles:


Home page
DevelopmentHome page
J. Bowles and P. Koopman
Retinoic acid, meiosis and germ cell fate in mammals
Development, October 1, 2007; 134(19): 3401 - 3411.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. Alton and T. Taketo
Switch from BAX-dependent to BAX-independent germ cell loss during the development of fetal mouse ovaries
J. Cell Sci., February 1, 2007; 120(3): 417 - 424.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
J. Bowles, D. Knight, C. Smith, D. Wilhelm, J. Richman, S. Mamiya, K. Yashiro, K. Chawengsaksophak, M. J. Wilson, J. Rossant, et al.
Retinoid Signaling Determines Germ Cell Fate in Mice
Science, April 28, 2006; 312(5773): 596 - 600.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Koubova, D. B. Menke, Q. Zhou, B. Capel, M. D. Griswold, and D. C. Page
Inaugural Articles: Retinoic acid regulates sex-specific timing of meiotic initiation in mice
PNAS, February 21, 2006; 103(8): 2474 - 2479.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K.-H. Tung, L. R. Wilkens, A. H. Wu, K. McDuffie, J. H. Hankin, A. M.Y. Nomura, L. N. Kolonel, and M. T. Goodman
Association of Dietary Vitamin A, Carotenoids, and Other Antioxidants with the Risk of Ovarian Cancer
Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 669 - 676.
[Abstract] [Full Text] [PDF]


Home page
Mol Biol EvolHome page
R.-Z. Liu, Q. Sun, C. Thisse, B. Thisse, J. M. Wright, and E. M. Denovan-Wright
The Cellular Retinol-Binding Protein Genes Are Duplicated and Differentially Transcribed in the Developing and Adult Zebrafish (Danio rerio)
Mol. Biol. Evol., March 1, 2005; 22(3): 469 - 477.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
E.-H. Park and T. Taketo
Onset and Progress of Meiotic Prophase in the Oocytes in the B6.YTIR Sex-Reversed Mouse Ovary
Biol Reprod, December 1, 2003; 69(6): 1879 - 1889.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. M. Matikainen, T. Moriyama, Y. Morita, G. I. Perez, S. J. Korsmeyer, D. H. Sherr, and J. L. Tilly
Ligand Activation of the Aromatic Hydrocarbon Receptor Transcription Factor Drives Bax-Dependent Apoptosis in Developing Fetal Ovarian Germ Cells
Endocrinology, February 1, 2002; 143(2): 615 - 620.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
Y. MORITA and J. L. TILLY
Sphingolipid Regulation of Female Gonadal Cell Apoptosis
Ann. N.Y. Acad. Sci., April 1, 2000; 905(1): 209 - 220.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morita, Y.
Right arrow Articles by Tilly, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morita, Y.
Right arrow Articles by Tilly, J. L.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ALPHA-AMANITIN